Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Early Cutaneous Manifestations of COVID-19: A Systematic Review and Public Health Implications.
Grover A, Choi F, Wang SP. Grover A, et al. WMJ. 2023 Dec;122(5):349-356. WMJ. 2023. PMID: 38180923 Free article.
RESULTS: Ninety-seven patients were included. Urticarial (24.7%) and maculopapular (22.7%) lesions were most common, followed by pernio (17.5%), vesicular (14.4%), papulosquamous (8.2%), and purpuric (5.1%) lesions. ...Although sample size is limited, all pur …
RESULTS: Ninety-seven patients were included. Urticarial (24.7%) and maculopapular (22.7%) lesions were most common, followed by pern …
A Systematic Review on the Treatment of Dermatosis Papulosa Nigra.
Maghfour J, Ogunleye T. Maghfour J, et al. J Drugs Dermatol. 2021 Apr 1;20(4):467-472. doi: 10.36849/JDD.2021.5555. J Drugs Dermatol. 2021. PMID: 33852246
While prevalent, treatment options are limited and the benign course of DPNs may cause them to be overlooked by clinicians. However, large and multiple lesions in cosmetically sensitive areas may be emotionally and socially distressful to patients. ...
While prevalent, treatment options are limited and the benign course of DPNs may cause them to be overlooked by clinicians. However, large a …
Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.
Seirafianpour F, Sodagar S, Pour Mohammad A, Panahi P, Mozafarpoor S, Almasi S, Goodarzi A. Seirafianpour F, et al. Dermatol Ther. 2020 Nov;33(6):e13986. doi: 10.1111/dth.13986. Epub 2020 Aug 6. Dermatol Ther. 2020. PMID: 32639077 Free PMC article.
It could be manifest most commonly as a maculopapular exanthamatous or morbiliform eruption, generalized urticaria or pseudo chilblains recognized as "COVID toes" (pernio-like acral lesions or vasculopathic rashes). During pandemic, Non-infected non-at risk patients with i …
It could be manifest most commonly as a maculopapular exanthamatous or morbiliform eruption, generalized urticaria or pseudo chilblains reco …
A Systematic Review of Histopathologic Surveys on Mucocutaneous Biopsies in Patients Developed COVID-19 Vaccine-Related Dermatologic Manifestations.
Salehi S, Sadeghi S, Kalantari Y, Goodarzi A. Salehi S, et al. Am J Dermatopathol. 2023 Jan 1;45(1):1-27. doi: 10.1097/DAD.0000000000002320. Epub 2022 Nov 7. Am J Dermatopathol. 2023. PMID: 36484603
Eruptions that underwent a biopsy were mostly described as erythematous maculopapular, papulosquamous, vasculitis-like, lichenoid, or urticarial lesions. Histopathology revealed spongiosis, interstitial, and perivascular lymphohistiocytic infiltration, erythrocyte e …
Eruptions that underwent a biopsy were mostly described as erythematous maculopapular, papulosquamous, vasculitis-like, lichenoid, or …